Lupin’s Ankleshwar Facility bags award
Lupin won the gold award at the 9th Annual Conference on Quality Management, organised by the American Society for Quality (ASQ) at a recently held...
Continue ReadingGUBBA PHARMA IN E NEWS
IPC registers 4 lakh ADRs since 2010 towards strengthening India specific drug safety database
The Ghaziabad-based Indian Pharmacopoeia Commission (IPC), the nodal coordinating centre (NCC) for Pharmacovigilance Programme of India (PvPI), has generated 4 lakh adverse drug reactions since...
Continue Reading
Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier
Arena Pharmaceuticals Inc. shares have nearly tripled since Chief Executive Amit Munshi took the helm in 2016 and now he’s setting a new course as...
Continue Reading
SK Life Science plots 2020 launch for now-approved seizure drug Xcopri
SK Life Science has set out to transform itself into a commercial biopharma company, and with its seizure med Xcopri now armed with an FDA...
Continue Reading
Senate confirms MD Anderson oncologist to head FDA
Stephen Hahn, M.D., has served as cancer center’s deputy president and chief operating officer since 2017 The U.S. Senate confirmed Stephen Hahn, M.D., as commissioner...
Continue Reading
Belgium invites Indian pharma & biotech cos to invest and utilise huge opportunities offered by the country
Belgium, the global pharma and life sciences hub in Europe, has invited Indian pharmaceutical and biotechnology companies to invest in Belgium and utilise the huge...
Continue Reading
Drugmakers Cut Prices 61% to Get on Coveted China List
Drugmakers including AstraZeneca Plc and Roche Holding AG agreed to cut prices of some of their newest innovative drugs in China by an average of...
Continue Reading
Aurobindo Pharma’s subsidiary to acquire business assets from Profectus BioSciences for $11.29 mn
Aurobindo Pharma said that Auro Vaccines LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc, which, in turn, is a 100% subsidiary of the...
Continue Reading
Novartis set to buy The Medicines Company in $9.7bn deal
Novartis has announced plans to acquire The Medicines Company (TMC), in a deal worth $9.7 billion. The company has confirmed that the purchase was decided...
Continue Reading